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This study focused on the cell activating capacity of extremely low frequency magnetic fields (ELF-MF) on human umbilical cord blood-derived
monocytes. Our results confirm the previous findings of cell activating capacity of ELF-MF (1.0 mT) in human monocytes, which was detected as an
increased ROS release. Furthermore, gene expression profiling (whole-genome cDNA array Human Unigene RZPD-2) was performed to achieve a
comprehensive view of involved genes during the cell activation process after 45 min ELF-MF exposure. Our results indicate the alteration of 986
genes involved in metabolism, cellular physiological processes, signal transduction and immune response. Significant regulations could be analyzed
for 5 genes (expression N2- or b0.5-fold): IL15RA (Interleukin 15 receptor, alpha chain), EPS15R (Epidermal growth factor receptor pathway
substrate 15— like 1), DNMT3A (Hypothetical protein MGC16121), DNMT3A (DNA (cytosine-5) methyltransferase 3 alpha), and one gene with
no match to known genes, DKFZP586J1624. Real-time RT-PCR analysis of the kinetic of the expression of IL15RA, and IL10RA during 45 min
ELF-MF exposure indicates the regulation of cell activation via the alternative pathway, whereas the delayed gene expression of FOS, IL2RA and the
melatonin synthesizing enzymeHIOMTsuggests the suppression of inflammatory processes. Accordingly, we suggest that ELF-MF activates human
monocytes via the alternative pathway.
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In previous studies, we showed the activating capacity of
extremely low frequency magnetic fields (ELF-MF) (50 Hz)
in murine macrophages [1,2], human umbilical cord blood-
derived monocytes and human acute monocytic leukaemia
(AML) cell line Mono Mac 6 [3]. We detected an increased
production of free radicals after 45 min ELF-MF exposure
(1.0 mT), indicating the activation of immune relevant cells,
which was mediated by the NADH-dependent pathway in
murine macrophages and in Mono Mac 6 cells, but by the
NADPH-dependent pathway in human monocytes. Both
represent major pathways in immune cells for the formation
of the superoxide radical anion (·O2
−), the precursor of other
reactive oxygen species (ROS). The generation of ROS is
essential to maintain homeostasis and constitutes an essential
host defence mechanism in monocytes. It is also necessary to
combat infections [4] by actively participating in physiolog-
ical process, such as cell growth, apoptosis, cellular
senescence [5], induction of intracellular signal transduction
pathways [6], regulation of gene transcription and response to
stress [7]. It is known that signal transduction from various
membrane receptors, e.g., cytokine receptors, is enhanced by
ROS by triggering concomitantly the activation of NAD(P)H
pathways followed by corresponding downstream signalling
pathways [8]. The activation of downstream pathways causes
a change in gene expression mainly by the modulation of the
activities of transcription factors [4,9].
It has been suggested that ELF-MF induces immune cell
activation [1–3,10,11], but the causal mechanism is not clear
yet. For immune cell activation, three different pathways are
described: the classical, the alternative, and the lectin-dependent
activation pathway. The classical activation pathway includes
the activation of inflammation, the destruction of the extracel-
lular matrix (ECM), and the induction of apoptosis. The
alternative activation pathway promotes ECM construction, cell
proliferation, and angiogenesis, and resolves inflammation. The
lectin pathway initiates inflammation, apoptosis and inhibits
cell growth in a comparable way to the classical activation
complex [12–15].
In this study, we used human umbilical cord blood-
derived monocytes positively responding to 1.0 mT 50 Hz
magnetic fields (45 min) with ROS production and applied a
genome wide gene expression analysis as a discovery science
approach to detect gene regulations after ELF-MF exposure.
Changes in a number of genes allowed us to formulate a
working hypothesis, namely the activation of the alternative
pathway by ELF-MF, which was tested by specific gene
analysis using real time RT-PCR. The expression of IL10RA,
IL15RA, IL2RA, FOS, and the melatonin synthesizing
enzyme hydroxyndole-O-methyltransferase (HIOMT) was
investigated after 5, 15, 30 and 45 min ELF-MF exposure,
to obtain specific information about the involved pathway.
Interleukin receptor 15 (IL15RA) was investigated, because it
was significantly upregulated according to the gene expres-
sion profiling. IL2RA was examined since both IL15RA and
IL2RA elicit similar biological effects indicating pro-inflammatory responses [16,17]. Furthermore IL10RA was
investigated to examine the induction of anti-inflammatory
response by ELF-MF. Since HIOMT is one key enzyme for
melatonin synthesis, and it is also responding to inflamma-
tion by upregulating IL-2 production [18], the time-
dependent regulation of the HIOMT gene was analyzed as
well. Finally, the immediate early response gene FOS, acting
as a transcription factor, was analyzed, since it is reported
[19,21] to be affected by ELF-MF.2. Material and methods
2.1. Cell culture
Human umbilical cord blood monocytes were derived from the maternal
end of the severed cord immediately after the birth and isolated as
previously described [3] within 24 h. Briefly, after the standard density
gradient Ficoll hypaque separation (density =1.077, PAA, Germany),
monocytes were separated from mononuclear cells using the CD14+ Cell
Isolation Kit and the MiniMacs separation unit (Miltenyi Biotec GmbH,
Germany). Cells were counted using a Neubauer cell count chamber and
seeded at a density of 0.5–1.0×106 cells/ml in RPMI 1640 containing 2 mM
L-glutamine (PAA, Germany), and 10% autologous serum [22]. Cells were
cultured at 37 °C in a humified atmosphere and 5% CO2 until the
experiments started.
2.2. Flow cytometric analysis of human monocytes
Characterization of human monocytes was evaluated by double-stained
labelling of 0.5×106 cells with anti-CD14-FITC and anti-CD69-PerCP antibody
(Becton Dickinson, Germany), representing monocytes (CD14+) in an early
activation stage (CD69+). A total of 5000 cells were analyzed per sample by using
the flow cytometer Epics Altra (Beckman Coulter, Germany) with a water -
cooled 488 nm Argon Laser. Fluorescence values were measured at 525 nm
(FITC conjugated antibodies) and at 610 nm (PerCP conjugated antibodies). The
percentage of CD14+/CD69+ and CD14+/CD69− cells were calculated by using
the software EXPO32 vs. 1.2 analysis (Beckman Coulter, Germany).
2.3. Exposure system
The ELF-MF exposure system consisting of a Helmholtz coil with a diameter
of 400mm, a distance between the coils of 200mm, a resistance of 2.1Ω and 154
turns of copper wire (Phywe Systeme, Germany) [23], was located inside a CO2 -
incubator (Binder, Germany) at 37 °C with a humified atmosphere and 5% CO2.
Cells were exposed in the central area of the coils to 50 Hz ELF-MF to 1.0 mT
flux density continuously monitored by precision F.W. Bell Model 4048 Gauss/
Tesla Meter (Bell, Orlando, USA). Control cells were cultured in an identical
incubator without a Helmholtz coil system in parallel.
2.4. Detection of reactive oxygen species
The production of reactive oxygen species was detected by using the dye
dihydrorhodamine 123 (DHR, Molecular Probes, The Netherlands), which
will be oxidized by ROS to the fluorescence dye rhodamine. Cells were
seeded in 96-well plates with flat bottom (TPP, Germany) at a density of
1×106/well and treated with 1 μM PMA (Sigma Aldrich, Germany) or 1 μg/
ml LPS (Sigma Aldrich, Germany), or exposed to ELF-MF for 45 min. After
exposure, cells were centrifuged and HBS including DHR solution (1 μM
final concentration) was added for 25 min as previously described [3]. The
fluorescence of rhodamine was measured by flow cytometry (Epics Altra,
Beckman Coulter, Germany) at 525 nm. Mean fluorescence intensity (X-
mean) was determined after gating monocytes by using the software EXPO32
vs. 1.2 analysis (Beckman Coulter, Germany). For each sample 2500 events
were acquired.
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respective control cells (E/C), whereas data of the time dependency are
expressed as the ratio of exposed to control cells at t=0 min (E/Ct0).
Columns show the arithmetic mean ratio±standard deviation (E/C±S.D.) of
the mentioned (n) independent experiments. Each measurement was carried
out in triplicates.
2.5. RNA preparation
Total cellular RNA was isolated from unexposed and ELF-MF exposed
monocytes by using the RNeasy Mini Kit (Qiagen, Germany). To collect the
appropriate amount of RNA for the gene expression profiling, pooled RNAwas
used from 28 independent experiments of 74 donors. For real-time PCR, RNA
was pooled from 5 and 6 donors and was used in 2 independent experiments. The
quality of all isolated RNA samples was determined by a GeneQuant Analyzer
(Pharmacia, Germany).
2.6. Human cDNA array
The cDNA array profilingwas performedwith RNA derived from unexposed
and ELF-MF exposedmonocytes. Total RNAwas pooled and concentrated using
the RNAMinElute Kit (Qiagen, Germany). RNA quality was measured using an
Agilent 2100 Bioanalyzer (Agilent Technologies).
For the cDNA array, 6.5 ng of RNA were used for labelling with α-CTP
(33P). Samples were added to the whole-genome cDNA array Human
Unigene RZPD-2 with 75.000 clones for a competitive hybridization (65 °C
for 17 h). Each array contains 2 spots for each clone. Since the experiments
were performed in duplicate, there were 4 spots potentially available for each
clone. At the end, the cDNA arrays were scanned using a phosphorimager
(Fuji FLA-3000). Background correction and normalized signal medium
intensities were extracted using Aida Version 3.23 software. The software
Array Vision analyzed the ratio of exposed to unexposed cells. Ratios of
≤0.5 and ≥2.0 were taken into consideration, if at least 3 of 4 spots were
appropriate.
2.7. Two step real-time RT-PCR
RNAwas isolated from unexposed and ELF-MF exposed monocytes after 0,
5, 15, 30 and 45 min in 2 independent experiments to determine time-dependent
gene regulation.
cDNA used for real-time PCR amplification was first synthesized from
150 ng total cellular RNA using 1st Strand cDNA Synthesis Kit for RT-PCR
(AMV) using oligo (dT) primer (Roche, Germany). PCR amplification was
performed using the LightCycler DNA Master SYBR Green I (Roche,
Germany) according to the manufacturer's protocol. The following transcript
specific oligonucleotide primers (Invitrogen, Germany), were used for PCR
amplification (LightCycler, Roche, Germany): IL2RA (197 bp, exon 4–5): (s)
atcagtgcgtccagggatac (as)gacgaggcaggaagtctcac; IL10RA (226 bp, exon 6–7):
(s)ttctttgcctttgtcctgct (as)gcaggtccaagttcttcagc; IL15RA (213 bp, exon 4–6): (s)
accttccacaggaaccacag (as)aggtagcatgccaggagaga; HIOMT (251 bp, exon 3–6):
(s)tctgtgtgtccctgaagctg (as)ggacctgtagatggccgtaa; FOS (366 bp, exon 1–3): (s)
ccggggatagcctctcttac (as)cccttcggattctccttttc; HPRT (345 bp, exon 3–6): (s)
acgtcttgctcgagatgtga (as)cttgcgaccttgaccatctt.
Crossing points (CP) values were obtained from the LightCycler software
Version 3.5, representing the PCR cycle at which an increase in fluorescence
intensity above a base line signal was first detected. Relative quantification of
the target gene signal was calculated by normalizing the target gene signal with
the hypoxanthine phosphoribosyl-transferase1 (HPRT) signal, whereas normal-
ization to β-actin or human acidic ribosomal protein (HUPO) did not yield
acceptable results.
The ratio of exposed to unexposed genes was calculated by the following
formula [24]:
Ratio ðE=CÞ ¼ 2−½DCP sample−DCP control ¼ Ratio ðE=CÞ
¼ 2−DDCP DCP ¼ CPHPRT−CPtarget gene
 Ratios for time dependency values were calculated to control values at t=0 min.
Results are expressed as the mean ratio±standard deviation (E/C±S.D.) of 4
data points obtained from 2 independent experiments.
2.7.1. Primer specificity
Specificity of real-time PCR products was documented with high resolution
gel electrophoresis and resulted in a single product with the desired length.
Additionally, melting curve analysis was performed after real-time PCR
amplification to determine the characteristic melting temperature of the target
cDNA. The melting temperature supplies information for product identification
and unwanted by-products (primer dimers). Analysis was accomplished using
the melting curve analysis tool of the LightCycler Software. Furthermore, PCR
products of each gene were pooled, run by gel electrophoresis, extracted using
the gel extraction kit (Qiagen, Germany) and sequenced.
2.8. Statistical analysis
Statistical analysis of ROS production was performed by using the one or
two way ANOVA and between investigated groups the Student's t test,
considering values Pb0.05 as significantly different. The SAMmethod [25] was
applied for statistical analysis for the gene expression profiling considering
clones with 4 good spots (38581 over 74 543 total clones corresponding to
51.8% ratio). The normalized difference diff(i) between rescaled values for each
clone i was calculated according to the following formula:
diff ið Þ ¼ E½expðiÞ−E½ctrlðiÞﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
rctrlðiÞ2
NG−1 þ
rexpðiÞ2
NG−1 þ s0
q ;
where exp(i) denotes the 4 spots related to the ith clone of the exposed cells,
ctrl(i) denotes the 4 spots related to the ith clone of the control cells, E[ ] is
for “expected value of “, and s0 is an additional correction term that removes
possible divergences in the denominator, calculated as the median of the σi
distribution for each clone. Genes are ranked by their diff(i) value – rank[diff
(i)] – and such ranking is compared with a “null” distribution (corresponding
to no EMF effect) obtained with a bootstrapping [26] procedure from the
dataset. Namely, P=36 new datasets are generated by means of permutations
of the original data (mixing ctrl and exp values), and diffp(i) (p referring to
the pth permutation) was calculated for these datasets. These differences were
ranked for each dataset – rank[diffp(i)] – and the average rank E[rank[diffp
(i)]] for each gene over all the permutations was calculated. A plot of rank
[diff(i)] versus Ediffp(i)diffp(i)] was generated, and the genes were chosen as
those that significantly deviated from the y=x line: the distance of rank[diff
(i)] from the y=x line, defined as dist(i), was to be larger than a threshold
value Δ=1.5.3. Results
3.1. Characterization of human umbilical cord blood
derived monocytes
The cell surface antigen CD14 is continuously expressed on
monocytes, whereas CD69 is expressed only at the early
activation stage. This characterization was necessary to show the
activation potency of the used cells and was performed before all
experimental applications. Flow cytometric analysis detected an
enrichment of 90–98% CD14+ monocytes, whereas ca. 30% of
these cells expressed CD69 (data not shown).
Determination of ROS production was performed to detect
the cell activating capacity of ELF-MF in human monocytes [3].
PMA treatment was carried out for ROS production as positive
control for cell activation [25], and only positively responding
Fig. 2. Time-dependent ROS production in human monocytes after 1.0 mT ELF-
MF exposure or treatment with 1 μM PMA or 1 μg/μl LPS for 5, 15, 30 or
45 min. PMA and LPS treatment were performed to induce cell activation
(positive controls). The bars represent the arithmetic mean of fluorescence
intensity (X-mean) as a ratio of exposed to control cells (t=0 min)±standard
deviation (E/Ct0±S.D.) of 3 independent experiments of 2, 7 and 4 donors.
Asterisks mark significant differences (Student's t test, Pb0.05) between
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gene expression profiling, showed a 1.5-fold significantly
increased ROS release after 45 min ELF-MF exposure (1.0 mT)
and a 4.3-fold increase after PMA treatment (Fig 1).
3.2. Time-dependent ROS production in human monocytes
Time-dependent ROS production was investigated in three
independent experiments of 2, 4, and 7 donors to obtain infor-
mation about the magnitude of activation capacity of ELF-MF
within 45-min exposure in human monocytes. PMA treatment
stimulates ROS production via a receptor independent [25] and
LPS via a receptor-dependent pathway [27], which were used as
positive controls.
ELF-MF induced a 1.4-fold increased ROS production already
after 5 min ELF-MF exposure, which remained constant over the
observed time period (Fig. 2). LPS treatment caused a significantly
increased ROS production at the same magnitude as ELF-MF
exposure, whereas the PMA induced ROS production was 10.5-
fold increased 5 min after treatment, which decreased to 6.0-fold
after 45 min (Fig. 2).
3.3. Gene expression profiling of human monocytes after 45 min
ELF-MF exposure
Changes in gene expression of human monocytes were
investigated after 45 min ELF-MF exposure using a whole-
genome cDNA array Human Unigene RZPD-2. The array was
provided with 75,000 clones, of which 38,581 clones including
5,356 annotated genes were expressed.
For analyzing the gene expression alterations, we considered
only changes with ≥2 or ≤0.5-fold, in at least 3 of 4 spots.
According to this evaluation protocol, we detected induced
alterations in 986 genes, of which 659 were upregulated and 327
were downregulated after 45 min ELF-MF exposure. Genes were
subdivided into groups concerning their biological function
referring to The Gene Ontology (GO) terms. Some genes are listed
in several groups as they contribute to more than one biological
function. The following functional categories were chosen: meta-
bolism, cellular physiological processes, signal transduction, res-Fig. 1. ROS production in humanmonocytes after exposure to 1.0 mT ELF-MF or
1 μM PMA for 45 min using the DHR assay. PMA treatment was performed as a
positive control for cell activation. The bars represent the arithmetic mean of
fluorescence intensity (X-mean) as a ratio of exposed to unexposed cells±standard
deviation (E/C±S.D.). Cells were derived from 78 donors, pooled and used in 28
independent experiments. Asterisks mark significant differences (Student's t test,ponse to stimulus, coagulation, extracellular matrix organisation
and biogenesis, cell homeostasis, development, oncogenesis, and
unknown genes. Nearly 17% of all regulated genes that were
detected are with unknown biological functions (Fig. 3A). Major
changes in gene expression were found in the metabolism group
(45.5%, Fig. 3B), including processes like transcription (FOS,
TAZ, DXYS155E, TCF8, HMG20A, COASTER), DNA
(PAPOLA) and RNA processing (MGEA6, BICD1, TRNT1,
SF3B3), and macromolecule metabolism involving protein
modifications (TRIM4, USP2), such as protein dephosphoryla-
tion and phosphorylation (SIRT5, PTPN18, ULK2, MLL3,
MKPX) (Table 1). Alterations in 27.4% of the total regulated
genes were detected in the category of cellular and physiological
processes. In this group genes encoding proteins for transport
processes (ATP1B2, ENTH, MLL3, NBEA, CHDH, SLC12A8),
but also for cell proliferation and cell cycle regulation (MACF1,
PDGFA, FHL2, TCF8, FGG, CDC6, MKPX, FHIT) were
regulated (Fig. 3B, Table 1).
Our results show that 21.6% of all regulated genes belong to
processes which are in the cell communication cluster,
including main changes in the signal transduction group (Fig.
3B). These genes mainly indicate regulations of cell surface
linked G-protein coupled receptor proteins and intracellular
signal cascade proteins (protein kinase C and small GTPases
mediated) (data not shown). Gene expression alterations were
also detected in MKPX, encoding the mitogen-activated protein
kinase phosphatase X, DXYS155E, PDGFA, and GUCY1A3
(Table 1). Furthermore, JAK3, PIAS1, SOCS4, TCF8, involved
in the JAK-STAT signalling, and MAPK14, component of the
MAPK cascade, were also regulated after ELF-MF exposure
(Tables 1 and 2).
Fig. 3. Alteration in gene expression of human monocytes exposed to 45 min ELF-MF (1.0 mT) using a whole human genome cDNA array including 38,581 genes.
Total RNA from 74 donors was isolated and pooled from human monocytes after exposure to ELF-MF or control conditions. Only genes were taken into account,
which were at least 2-fold upregulated or downregulated. (A) Upregulated and downregulated genes were subdivided into groups regarding to their biological function:
cell communication, cell physiological processes, response to stimuli, metabolisms, coagulation, extra cellular matrix organisation and biogenesis, cell homeostasis,
development and oncogenesis. Genes encoding proteins with unknown function are summarised as unknown. (B) The four major groups, metabolism, cellular
physiological process, cell communication and response to stimuli, were subdivided into more specific physiological functions. Bars represent the numbers of
regulated genes, whereas some genes are mentioned in more than one cluster as they contribute to more than one biological function. Numbers in brackets indicate the
percentage of the total 986 regulated genes.
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Table 1
Genes with an upregulation (≥5-fold) or downregulation (≤0.2-fold), asterisk
marks significant changes of genes with an upregulation of at least ≥2-fold or
downregulation at least of≤0.5-fold, using SAM analysis and a two-tailed t test
(P=0.001), in human monocytes after 45 min ELF-MF exposure
Gene Cluster description Mean (ratio)
Down regulation
ATP1B2 ATPase, Na+/K+ transporting, 0.05
TRIM4 tripartite motif-containing 4 0.07
MGEA6 meningioma expressed antigen 6 0.1
SIRT5 sirtuin 5 (S. cerevisiae) 0.2
GUCY1A3 guanylate cyclase 1, alpha 3 0.2
MATN1 matrilin 1, cartilage matrix protein 0.2
PTPN18 protein tyrosine phosphatase,
non-receptor type 18
0.2
MGC16121 Hypothetical protein MGC16121 0.4*
DNMT3A DNA (cytosine-5) methyltransferase
3 alpha
0.5*
Up regulation
IL20RA interleukin 20 receptor, alpha 103.9
PSMC2 proteasome (prosome, macropain)
26S subunit, ATPase, 2
71.7
FOS v-fos FBJ murine osteosarcoma
viral oncogene homolog
56.3
JADE-1 PHD protein Jade-1 33.9
ULK2 unc-51-like kinase 2 (C. elegans) 26.1
BICD1 Bicaudal D homolog 1 (Drosophila) 19.4
SON SON DNA binding protein 17.4
TAZ transcriptional co-activator with
PDZ-binding motif (TAZ)
16.3
TRBβ T cell receptor beta locus 14.5
TRNT1 tRNA nucleotidyl transferase,
CCA-adding, 1
13.1
SF3B3 splicing factor 3b, subunit 3 11.5
TOP3A topoisomerase (DNA) III alpha 10.0
CNP 2-,3-cyclic nucleotide 3- phosphodiesterase 9.5
PAPOLA poly(A) polymerase alpha 8.1
ENTH enthoprotin 7.8
DXYS155E DNA segment on chromosome
X and Y (unique)
155 expressed sequence
7.7
MLL3 myeloid/lymphoid or
mixed-lineage leukemia3
7.2
MACF1 microtubule-actin crosslinking factor 1 7.0
RINZF zinc finger protein RINZF 6.9
MORF4L2 mortality factor 4 like 2 6.9
EIF2B3 eukaryotic translation initiation
factor 2B
6.5
USP2 ubiquitin specific protease 2 6.3
NBEA neurobeachin 6.3
PFKFB1 6-phosphofructo-2-kinase/fructose-2,
6-biphosphatase 1
6.3
PDGFA platelet-derived growth factor
alpha polypeptide
6.2
CDCA1 cell division cycle associated 1 6.0
TRIM15 tripartite motif-containing 15 5.8
FHL2 four and a half LIM domains 2 5.6
CHDH choline dehydrogenase 5.5
TCF8 transcription factor 8 5.5
SGT small glutamine-rich tetratricopeptide
repeat (TPR)-containing
5.4
HMG20A high-mobility group 20A 5.4
FGG fibrinogen, gamma polypeptide 5.1
CBX5 chromobox homolog 5
(HP1 alpha homolog, Drosophila)
5.1
COASTER coactivator for steroid receptors 5.1
Table 1 (continued)
Gene Cluster description Mean (ratio)
Up regulation
CDC6 CDC6 cell division cycle 6 homolog
(S. cerevisiae)
5.1
MKPX mitogen-activated protein
kinase phosphatase x
5.1
FHIT fragile histidine triad gene 5.0
SLC12A8 solute carrier family 12, member 8 5.0
DKFZP586J1624 Unknown 6.3*
EPS15R Epidermal growth factor receptor pathway
substrate 15 - like 1
2.8*
IL15RA Interleukin 15 receptor, alpha chain 2.6*
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regulated genes after ELF-MF exposure (Fig. 3B). Within this
cluster, main changes were detected in the category of defence
response including genes for regulation of the immune
response, such as FOS, TRB, DXYS155E, and TCF8. Genes
for the IL-20 receptor alpha chain (IL20RA) and cyclic
nucleotide phosphodiesterase (CNP), which, respectively,
signal responses to stress (defence response), were also
regulated (Table 1). Downregulations for the chemokine
receptor CCL19 and CCL27 and upregulations for the immune
responding genes IL-1F5 and C3, indicate activation of immune
cells (Table 2).
A further evaluation of data using the Statistical Analysis of
Micro array (SAM) was applied, where clones with 4 good quality
spots were taken into consideration. According to this evaluation
protocol, 36 significantly upregulated and 51 downregulated genes
were detected (data not shown). All these clones resulted also in
significant changeswith respect to a two-tailed t test withP=0.001.
If regulation of ≥2-fold or ≤0.5-fold were taken into consider-
ation, only 12 upregulated and 31 downregulated genes could be
detected. Only 4–5 genes are belonging to known genes, whereas
significant gene alterations were detected mainly in, so far,
unknown genes. The DKFZP586J1624 (6.3-fold), EPS15R (2.8-
fold), and IL15RA (2.6-fold) genes were upregulated, while
MGC16121 (0.4-fold), and DNMT3A (0.5-fold) wereTable 2
Genes with an upregulation (≥2-fold) or downregulation (≤0.5-fold) in human
monocytes after 45 min ELF-MF exposure regarding to the gene ontology group
immune response
Gene Cluster description Mean
(ratio)
Down regulation
CCL27 chemokine (C–C motif) ligand 27 0.3
CCL19 chemokine (C–C motif) ligand 19 0.4
Up regulation
PIASY protein inhibitor of activated STAT protein PIASy 2.7
MAPK14 mitogen-activated protein kinase 14 2.7
SOCS4 suppressor of cytokine signalling 4 2.6
C3 complement component 3 2.3
IL1F5 interleukin 1 family, member 5 (delta) 2.2
JAK3 Janus kinase 3 (a protein tyrosine kinase, leukocyte) 2.1
Fig. 4. Changes of gene expression for IL15RA (A), IL2RA (B), IL10RA (C),
HIOMT (D) and FOS (E) after 5, 15, 30, 45 min ELF-MF exposure in human
monocytes; performed by using the real-time RT-PCR. Data represent the
arithmetic mean ratio to control (t=0 min)±standard deviation (E/Ct0±S.D.) of
2 independent experiments carried out in duplicates. Values were normalized to
hypoxanthine phosphoribosyl-transferase1 (HPRT) and ratios were calculated
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the IL-15 receptor and acting as a regulatory factor during
inflammation was significantly upregulated. EPS15R is related to
endocytosis and DNMT3A is involved in DNAmethylation which
could be a good link to cell activation processes, while the
biological function of DKFZP586J1624 and MGC16121 is not
clear yet.
3.4. Kinetics of gene expression
Gene expression profiling showed a significant change of
IL15RA regulation, encoding the cytokine receptor α chain for
IL-15. Therefore, we investigated the IL15RA expression
during 45 min ELF-MF exposure using real-time RT-PCR. In
addition, we also studied the IL2RA expression, since both
IL15RA and IL2RA share the β and γ chain of the IL-2
receptor. They hereby contribute to similar signalling cascades
in the pro-inflammatory immune response. IL10RA encoding
the α chain for IL-10 receptor is also involved in the immune
response by representing an anti-inflammatory function,
therefore IL10RA gene expression was also studied.
The kinetics of the gene expression showed a divergent regu-
lation of the 3 cytokine receptors IL15RA, IL2RA, and IL10RA in
human monocytes during 45 min ELF-MF exposure (Fig. 4A–C).
The upregulation of IL10RA and a downregulation of IL15RA
were already induced after 15 min ELF-MF exposure, whereas no
regulation of IL2RAwas observed at that time point. The regulation
of IL10RA and IL15RA reached the control level after 30 min,
whereas an upregulation could be observed for IL2RA, which was
decreased to the control level after 45 min.
The early response gene FOS was upregulated whereas the
melatonin synthesizing enzyme HIOMT was not regulated in
the gene expression profiling. Since their encoded proteins are
involved in the immune response we studied the gene
expression kinetics for these genes as well. Interestingly,
HIOMT was downregulated for the first 30 min, but reached
the control level again after 45 min exposure (Fig. 4D)
confirming the array result. The FOS encoding gene was not
regulated for the first 15 min, but we detected an elevated
expression after 30 min exposure, which was regulated towards
the control level after 45 min (Fig. 4E), not identical to the array
data. All data were compared to the control value t=0 min. It
should be pointed out that the RT-PCR studies were carried out
in two independent experiments using different donors than for
the array screening, which could be the reason for the
inconsistent results.
4. Discussion
This study focused on the capacity of ELF-MF to activate
human umbilical cord blood-derived monocytes resulting in an
increased release of free radicals. Gene regulation in ELF-MF
exposed monocytes was investigated to achieve a general view
of involved activating pathway(s). However, previous studies
have already shown the activating capacity of ELF-MF in
murine macrophages, human Mono Mac 6 cells and human
monocytes by an increased free radical production [1,3], as well
Fig. 5. Induction of the alternative activation pathway in human monocytes during 1.0 mT ELF-MF exposure. Cell activating capacity was immediately detected as an
increased ROS production after ELF-MF exposure, where we assume that the cell activation is mediated via a non-identified receptor-dependent pathway.
Subsequently, ROS initiates the expression of cytokine signalling by an increased expression of the transcription factor FOS, resulting in an increased cytokine release
causing the expression of the cytokine receptor IL15RA and IL2RA – two pro-inflammatory cytokine receptors – and IL10RA, indicating an anti-inflammatory
response. Thus, cytokine signalling maintains ROS release and FOS expression via the MAPK cascade, while JAK-STAT cascade via IL2 and IL15 receptor might be
suppressed by the decreased melatonin production, indicated by a decreased expression of the HIOMT gene, and by the expression of genes encoding proteins for
inhibiting IL-2 production (e.g., TCF8) and JAK-STAT signalling (SOCS4). Therefore, we assume that no inflammation is induced by ELF-MF. Furthermore, gene
expression profiling and gene kinetic analysis confirm that inflammation is resolved and cell proliferation, ECM construction, and angiogenesis are promoted,
indicating the involvement of the alternative pathway.
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production [29] in murine macrophages.
Our results confirm the cell activating capacity of ELF-MF
in human monocytes and emphasize the influence of ELF-MF
on the used immune cells by a significant increased ROS release
already after 5 min ELF-MF exposure, which remained constant
over the observed time period (45 min). Furthermore, our results
confirm the assumption that ELF-MF activates monocytes via a
receptor-dependent pathway similar to LPS, since the ELF-MF
induced ROS release was detected at the same magnitude as
LPS. It was shown that the LPS receptor encoding gene is 2-fold
upregulated after cell activation in the gene expression profiling
[30], which is initiated when LPS-binding protein (LBP)3
transfers LPS to CD14 on the surface of cells. LPS-CD14
complexes then signal via Toll-like receptors to activate NF-κB
as well as the extracellular regulated kinase, c-Jun N-terminal
kinase, and p38 mitogen-activated protein kinases, all of which
mediate the production of inflammatory cytokines [30].
In contrast, PMA treatment induces cell activation via a receptor
independent pathway, causing a ROS release initiating theinduction of an oxidative burst. The rise of the intracellular oxidant
level produced by ELF-MF, PMA or LPS, can result in two
potentially important effects: (i) damage to various cell components
and triggering the activation of specific signalling pathways [4], and
(ii) ROS play an important role as second messenger involved in
downstream signalling, resulting in turning on geneswith important
functions in the immune response and/or cellular physiological
processes such as cell proliferation [6,31].
To obtain an indication of gene regulation after 45-min
ELF-MF exposure of monocytes, gene expression profiling
was carried out. The gene expression pattern of the pooled
RNA of 78 donors shows regulation of 986 genes after only
one time point, namely after 45 min ELF-MF exposure. Our
result shows alteration of signal transduction and immune
response related genes, although the main changes were
detected of genes referring to metabolism and cellular
physiological processes.
Statistical analysis indicated the significant regulation of 5
annotated genes (DKFZP586J1624, EPS15R, IL15RA,
MGC16121, and DNMT3A) with 4 good quality spots. Since we
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IL15RA, encoding theα chain of the interleukin receptor for IL-15.
IL-15 is a cytokine and structurally related to IL-2, eliciting similar
biological effects in vitro, explained by the common usage of the
IL-2 β-γ signalling complex. Both cytokines trigger similar
downstream signalling pathways including the activation of Jak-1/
Jak-3 tyrosine kinases, Lck and Syk tyrosine kinases, the MAPK
pathways, and induction of Bcl-2 [16,17].
Our results on gene expression profiling show (see Tables 1
and 2) the upregulation of JAK3 and MAPK14, encoding
proteins involved in the JAK-STAT or MAPK signalling
pathway. JAK-STAT cascade suppressing genes such as
PIAS1, SOCS4 and TCF8, an IL-2 suppressor were also
regulated at the observed time. However, the activation of the
MAPK pathway seems to initialize the activation of small
GTPases, which are molecular switches that use a simple
biochemical strategy to control complex cellular processes.
Various small GTPases were upregulated, mainly belonging to
the major groups Ras, Rho (Rac), and Rab. One of the most
interesting aspects of these regulatory GTPases is that they also
regulate a variety of biochemical pathways including MAPK
pathway, and the phagocytotic NADPH oxidase pathway [32].
A common effect of the activation of signal transduction
pathways, e.g., MAPK pathway or NADPH pathway, is the
modulation of transcription factors such as FOS. FOS can also
be regulated by ROS, initiating gene expression important for
immune response [31,33], and also implicated in the regulation
of cell proliferation [34]. FOS activation has been reported by
other research groups after ELF-MF exposure as well [19–21].
Therefore, we assume that FOS plays a central role during ELF-
MF exposure, since our results of the gene expression profiling
show more upregulations than downregulations in the group
“response to stimulus (immune response)”. Additionally,
upregulation of various genes regarding cell proliferation (e.g.,
platelet-derived growth factor alpha polypeptide—PDGFA)
[35] and angiogenesis (e.g., vascular epidermal growth factor—
VEGF) [36] were also detected.
Taken together, the array data indicate that ELF-MF activate
human monocytes directly or indirectly via the alternative
pathway. Consequently, inflammation is not induced, shown
also by the significant upregulation of IL15RA and SOCS4 as
well as TCF8, which are suppressors of interleukin signalling.
Our assumption is furthermore supported by the downregulation
of chemokine genes CCL19 and CCL27, usually involved in
inflammatory response. di Luzio and co-workers have described
that the two inflammatory chemokines MCP-1 and RANTES
were downregulated in human monocytes exposed to ELF-MF
(50 Hz, 1.0 mT) for 24 h at the protein level [37]. In addition,
initiation of IL-1F3 release [38] counteracts inflammatory
processes [39]. Our result in the gene expression profiling
showed an upregulation of IL-1F5, which is closely phyloge-
netically related to IL-1F3 [40].
To elucidate the involvement of the alternative pathway
during the activation of ELF-MF exposed monocytes, the
kinetics of the IL15RA gene was analyzed by real-time RT-
PCR. Furthermore, IL2RA was investigated, since both
IL15RA and IL2RA indicate pro-inflammatory responses.IL10RA was also examined for gene expression as it is
involved in the anti-inflammatory response. The gene encod-
ing HIOMT and the FOS gene, which are involved in the
immune response, were also observed to obtain more
information of cell activation processes during 45 min ELF-
MF exposure. Our results show the upregulation of IL10RA
after 15 min, mediating the immunosuppressive signal of IL-
10 and inhibiting the synthesis of pro-inflammatory cytokines
[28]. IL15RA regulating pro- inflammatory processes, was
already downregulated at that time point, demonstrating the
repression of inflammatory response. IL2RA expression,
which is associated with adaptive immunity, was not regulated
at 15 min, but it showed an upregulation at 30 min. It has been
shown that monocytes do express IL2RA on their cell surface
resulting in an increase of ROS [41]. The downregulation of
IL2RA at the end of exposure to the control level can be
explained by the increased expression of the IL-2 suppressor
TCF8 shown in the array analysis, which inhibits the IL-2
production and hereby the IL2RA expression [42,43].
Besides, HIOMT encoding an enzyme involved in melatonin
synthesis [44], and in the increase in IL-2 production [18], was
downregulated during ELF-MF exposure, as shown with the RT-
PCR analysis. Some studies have shown that ELF-MF inhibited
the production of melatonin and the authors linked a low level of
melatonin to breast cancer and other tumour development (for
review, see [45]). One of the functions of melatonin is the action
as a receptor independent free radical scavenger. Downregulation
of melatonin synthesizing enzymes can cause a lack of free
radical scavenger in a biological system. A recently published
study showed that melatonin is synthesized in human lympho-
cytes, and is therefore involved in inflammatory processes [18]. A
downregulation of melatonin synthesis enzymes such as HIOMT
could be an indication of the absence of acute inflammatory
processes.
FOS expression seems to be activated by ROS, which is
immediately induced by ELF-MF via a receptor-dependent
pathway, although the receptor has not been identified yet.
Consequently, the induction of FOS leads to cytokine release
and to the expression of their cytokine receptors, leading to the
activation of a cytokine signalling pathway, causing the
modulation of the activities of transcription factors such as
FOS [4,9]. Cytokine signalling is also maintained by the
production of ROS via the MAPK cascade, affecting the FOS
expression. The JAK-STAT signalling induced by IL2 and IL15
receptor seems to be inhibited by specific suppressors and
possibly by a decreased melatonin production (Fig. 5).
Our results from the gene expression profiling simply
represent the average of 78 donors at one time point during
cell activation, while the investigation of real-time RT-PCR
analysis displays the average of gene expression of two
independent experiments, derived from 5 and 6 different donors,
respectively. The individuality of each experiment explains the
wide standard deviation of the gene expression investigations
during 45 min ELF-MF exposure in monocytes. We do not
expect any improvement of the data set by several repetitions,
because of the different donors. Therefore, no statistical analysis
could be performed for real-time RT-PCR data. However, the
411M. Lupke et al. / Biochimica et Biophysica Acta 1763 (2006) 402–412present study shows upregulation or downregulation tendencies,
which are discussed in the present paper.
In summary, we showed the cell activating capacity of ELF-
MF in human monocytes for the release of ROS. Alterations in
gene expression and real-time RT-PCR analysis of IL15RA,
IL2RA, IL10RA, HIOMT and FOS confirmed the assumption
that ELF-MF activates human umbilical cord blood-derived
monocytes directly or indirectly via the alternative pathway.
Further investigations have to be performed to confirm this
assumption.
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